Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Sensors (Basel) ; 19(20)2019 Oct 14.
Article in English | MEDLINE | ID: mdl-31615138

ABSTRACT

Simultaneous recordings of electroencephalogram (EEG) and functional magnetic resonance imaging (fMRI) are at the forefront of technologies of interest to physicians and scientists because they combine the benefits of both modalities-better time resolution (hdEEG) and space resolution (fMRI). However, EEG measurements in the scanner contain an electromagnetic field that is induced in leads as a result of gradient switching slight head movements and vibrations, and it is corrupted by changes in the measured potential because of the Hall phenomenon. The aim of this study is to design and test a methodology for inspecting hidden EEG structures with respect to artifacts. We propose a top-down strategy to obtain additional information that is not visible in a single recording. The time-domain independent component analysis algorithm was employed to obtain independent components and spatial weights. A nonlinear dimension reduction technique t-distributed stochastic neighbor embedding was used to create low-dimensional space, which was then partitioned using the density-based spatial clustering of applications with noise (DBSCAN). The relationships between the found data structure and the used criteria were investigated. As a result, we were able to extract information from the data structure regarding electrooculographic, electrocardiographic, electromyographic and gradient artifacts. This new methodology could facilitate the identification of artifacts and their residues from simultaneous EEG in fMRI.


Subject(s)
Algorithms , Artifacts , Electroencephalography , Magnetic Resonance Imaging , Nonlinear Dynamics , Electrooculography , Humans , Noise
2.
Pharmacol Biochem Behav ; 122: 212-21, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24631484

ABSTRACT

In the present study we investigated the potential antipsychotic effects of the mGlu2/3 agonist LY379268 on changes in EEG power spectra and coherence in the ketamine model of psychosis. In order to use behaviorally active drug doses, experiments detecting changes in locomotor activity and sensorimotor gating were also conducted. In EEG experiments, adult male Wistar rats were injected with ketamine 30 mg/kg i.p. and LY379268 3 mg/kg i.p. Cortical EEG was recorded from twelve (2 × 6) electrodes placed homolaterally on each hemisphere. To avoid interference with the behavioral hyperactivity of ketamine challenge, the behavioral activity of animals was simultaneously registered at the time of recording. Subsequent power spectral and coherence analyses were assessed in epochs corresponding to behavioral inactivity. Analysis of segments with behavioral activity compared to inactivity was also performed. The effects of LY379268 3 mg/kg i.p. on the deficits in sensorimotor processing and on hyperlocomotion induced by ketamine were evaluated in the test of prepulse inhibition of acoustic startle reaction (PPI ASR) and in the open field. LY379268 reversed the ketamine-induced hyperlocomotion but had no effect on ketamine-induced PPI deficits. In EEG epochs corresponding to behavioral inactivity ketamine decreased the power in the delta band, induced a power increase in the high frequency bands and globally decreased EEG coherence. Pretreatment with the LY379268 completely reversed the ketamine-induced power increase in high frequency bands and had a partial effect on EEG coherence. LY379268 alone induced a decrease of beta, high beta and low-gamma power, and an increase in coherence in high frequency bands. Additional analysis revealed that behavioral activity increases power as well as coherence in most frequency bands. In conclusion, agonism of mGlu2/3 receptors was effective in reversing most of the changes induced by ketamine, however due to the lack of effectiveness on PPI deficits its potential antipsychotic properties remain disputable.


Subject(s)
Amino Acids/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/therapeutic use , Disease Models, Animal , Electroencephalography/drug effects , Psychotic Disorders/drug therapy , Receptors, Metabotropic Glutamate/agonists , Amino Acids/pharmacology , Animals , Antipsychotic Agents/pharmacology , Antipsychotic Agents/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/pharmacology , Electroencephalography/methods , Ketamine/toxicity , Male , Psychotic Disorders/physiopathology , Rats , Rats, Wistar , Treatment Outcome
3.
J Psychiatr Res ; 46(2): 219-25, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21937059

ABSTRACT

OBJECTIVES: The aim of the study was to examine whether the change of quantitative EEG (QEEG) theta prefrontal cordance after one week of various antidepressive interventions predicts response to a 4-week treatment in patients with bipolar depression. METHODS: We investigated 20 inpatients who completed a 4-week treatment. EEG data were monitored at baseline and after 1 week of treatment. QEEG cordance was computed at 3 frontal electrodes (Fp1, Fp2, Fz) in theta frequency band. Depressive symptoms and clinical status were assessed using Montgomery-Åsberg Depression Rating Scale (MADRS), Clinical Global Impression (CGI) and Young Mania Rating Scale (YMRS). RESULTS: Seven of 8 responders (reduction of MADRS ≥50%) and only 2 of 12 non-responders had decreased prefrontal theta cordance value after the first week of treatment (p = 0.02). The positive and negative predictive values of cordance reduction for response were 0.78 and 0.91, respectively. We also found significant differences in cordance value reductions between responders and non-responders after week 1 and higher baseline cordance in responders. CONCLUSION: The change in prefrontal theta cordance was associated with subsequent change in depressive symptoms and potentially might be a useful tool in the early detection of acute response to antidepressive interventions in bipolar depressed patients.


Subject(s)
Antidepressive Agents/therapeutic use , Bipolar Disorder/drug therapy , Bipolar Disorder/pathology , Prefrontal Cortex/drug effects , Theta Rhythm/drug effects , Adult , Electroencephalography , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pilot Projects , Predictive Value of Tests , Prefrontal Cortex/physiopathology , Psychiatric Status Rating Scales , ROC Curve , Statistics, Nonparametric , Theta Rhythm/physiology
4.
Neuropsychobiology ; 63(4): 202-18, 2011.
Article in English | MEDLINE | ID: mdl-21422767

ABSTRACT

AIMS: This study was designed to evaluate the changes in EEG power spectra and EEG coherence in a ketamine model of psychosis in rats. Analyses of behavioral measurements--locomotion and sensorimotor gating--and the pharmacokinetics of ketamine and norketamine were also conducted. METHODS: Ketamine and norketamine levels in rat sera and brains were analyzed by gas chromatography-mass spectrometry after ketamine 30 mg/kg (i.p.). Ketamine 9 and 30 mg/kg (i.p.) were used in the behavioral and EEG experiments. Locomotor effects in an open field test and deficits in prepulse inhibition of acoustic startle reaction (PPI ASR) were evaluated in the behavioral experiments. EEG signals were simultaneously recorded from 12 implanted active electrodes; subsequently, an EEG power spectral and coherence analysis was performed. RESULTS: Ketamine had a rapid penetration into the brain; the peak concentrations of the drug were reached within 15 min after administration. Ketamine induced marked hyperlocomotion and deficits in the PPI ASR. EEG spectral analysis mainly showed increases in EEG power as well as coherence. These were most robust at 10-15 min after the administration and influenced all parts of the spectrum with ketamine 30 mg/kg. CONCLUSIONS: Ketamine at behaviorally active doses induces a robust increase in EEG power spectra and coherence. The maximum levels of change correlated with the kinetics of ketamine.


Subject(s)
Brain Waves/drug effects , Electroencephalography/drug effects , Ketamine/pharmacology , Ketamine/pharmacokinetics , Locomotion/drug effects , Psychotic Disorders/physiopathology , Sensory Gating/drug effects , Acoustic Stimulation , Animals , Brain/drug effects , Brain/metabolism , Brain/physiology , Disease Models, Animal , Dose-Response Relationship, Drug , Male , Psychotic Disorders/metabolism , Rats , Rats, Wistar
5.
Eur Neuropsychopharmacol ; 20(7): 459-66, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20421161

ABSTRACT

UNLABELLED: The aim of the study was to examine whether the reduction of theta prefrontal quantitative EEG (QEEG) cordance after one week of bupropion administration is a predictor of response to a 4-week treatment in patients that had failed to respond to previous antidepressant treatments. METHOD: EEG data of 18 inpatients were monitored at baseline and after one week. QEEG cordance was computed at 3 frontal electrodes (Fp1, Fp2, Fz). Response to treatment was defined as a >/=50% reduction of MADRS score. RESULTS: Nine of the eleven responders and one of the seven non-responders showed decreased prefrontal cordance value after the first week of treatment (p=0.01). Positive and negative predictive values of cordance reduction for the prediction of response to the treatment were 0.9 and 0.75, respectively. CONCLUSION: Similar to other antidepressants, the reduction of prefrontal QEEG cordance might be helpful in the prediction of the acute outcome of bupropion treatment.


Subject(s)
Antidepressive Agents/pharmacology , Bupropion/pharmacology , Depression/pathology , Prefrontal Cortex/physiopathology , Theta Rhythm/drug effects , Adult , Antidepressive Agents/therapeutic use , Bupropion/therapeutic use , Depression/drug therapy , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prefrontal Cortex/drug effects , Statistics, Nonparametric , Theta Rhythm/methods
6.
Neuro Endocrinol Lett ; 29(6): 895-901, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19112384

ABSTRACT

OBJECTIVES: Cognitive behaviour therapy (CBT) of primary insomnia is frequently combined with various pharmacological treatments, including sedative antidepressants. The present study was undertaken to evaluate the clinical efficacy of CBT, singly and combined with trazodone pharmacotherapy, for primary insomnia. DESIGN AND SETTING: Randomised, comparative clinical trial, at a single academic medical centre. METHODS: Twenty outpatients (15 women, 5 men) with chronic primary insomnia were randomly assigned to CBT or CBT +100mg trazodone and treated for 8 weeks. The treatment outcome was estimated by mean changes from baseline in self-reported clinical scales, sleep continuity data and sleep architecture parameters. RESULTS: All patients perceived significant subjective sleep improvements. Sleep latency significantly shortened (p=0.03), sleep efficiency increased (p=0.004) and the total sleep time was significantly prolonged (p=0.006) after the CBT treatment in both groups. Sleep architecture showed that the combined approach (CBT + trazodone) resulted in a significant increase in slow wave sleep duration compared to treatment by CBT only (p=0.04). CONCLUSIONS: CBT, singly and combined with the sedative antidepressant trazodone, is effective for the short-term management of chronic primary insomnia. Trazodone combined with CBT significantly increases slow wave sleep duration and this influence seems to be unrelated to its antidepressant effect.


Subject(s)
Cognitive Behavioral Therapy/methods , Hypnotics and Sedatives/therapeutic use , Sleep Initiation and Maintenance Disorders/therapy , Trazodone/therapeutic use , Adult , Antidepressive Agents, Second-Generation/therapeutic use , Combined Modality Therapy , Female , Humans , Male , Middle Aged , Polysomnography , Treatment Outcome
7.
Neuropsychobiology ; 58(1): 1-10, 2008.
Article in English | MEDLINE | ID: mdl-18781085

ABSTRACT

The aim of our study was to detect changes in the distribution of electrical brain activity in schizophrenic patients who were antipsychotic naive and those who received treatment with clozapine, olanzapine or risperidone. We included 41 subjects with schizophrenia (antipsychotic naive = 11; clozapine = 8; olanzapine = 10; risperidone = 12) and 20 healthy controls. Low-resolution brain electromagnetic tomography was computed from 19-channel electroencephalography for the frequency bands delta, theta, alpha-1, alpha-2, beta-1, beta-2 and beta-3. We compared antipsychotic-naive subjects with healthy controls and medicated patients. (1) Comparing antipsychotic-naive subjects and controls we found a general increase in the slow delta and theta frequencies over the fronto-temporo-occipital cortex, particularly in the temporolimbic structures, an increase in alpha-1 and alpha-2 in the temporal cortex and an increase in beta-1 and beta-2 in the temporo-occipital and posterior limbic structures. (2) Comparing patients who received clozapine and those who were antipsychotic naive, we found an increase in delta and theta frequencies in the anterior cingulate and medial frontal cortex, and a decrease in alpha-1 and beta-2 in the occipital structures. (3) Comparing patients taking olanzapine with those who were antipsychotic naive, there was an increase in theta frequencies in the anterior cingulum, a decrease in alpha-1, beta-2 and beta-3 in the occipital cortex and posterior limbic structures, and a decrease in beta-3 in the frontotemporal cortex and anterior cingulum. (4) In patients taking risperidone, we found no significant changes from those who were antipsychotic naive. Our results in antipsychotic-naive patients are in agreement with existing functional findings. Changes in those taking clozapine and olanzapine versus those who were antipsychotic naive suggest a compensatory mechanism in the neurobiological substrate for schizophrenia. The lack of difference in risperidone patients versus antipsychotic-naive subjects may relate to risperidone's different pharmacodynamic mechanism.


Subject(s)
Antipsychotic Agents/pharmacology , Brain Mapping/methods , Brain/drug effects , Electroencephalography/drug effects , Schizophrenia/diagnosis , Adult , Antipsychotic Agents/therapeutic use , Benzodiazepines/pharmacology , Benzodiazepines/therapeutic use , Brain/pathology , Brain/physiopathology , Brain Mapping/instrumentation , Clozapine/pharmacology , Clozapine/therapeutic use , Electroencephalography/instrumentation , Electroencephalography/methods , Female , Humans , Male , Olanzapine , Reference Values , Risperidone/pharmacology , Risperidone/therapeutic use , Schizophrenia/drug therapy , Schizophrenia/physiopathology , Signal Processing, Computer-Assisted , Young Adult
8.
Neuro Endocrinol Lett ; 29(3): 295-302, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18580843

ABSTRACT

BACKGROUND: QEEG cordance and low-resolution electromagnetic tomography (LORETA) are relatively new applications of QEEG. Four small-scale studies have shown that decreases of QEEG prefrontal theta cordance after the first week on new antidepressants predict clinical response to treatment in patients with unipolar depression. METHODS: We calculated prefrontal theta cordance and changes in 3D distribution of brain electrical activity using LORETA in the case of a 54-year old man experiencing his third depressive episode. RESULTS: We did not detect a decrease of prefrontal theta cordance after one week of new treatment and the patient did not respond to this therapy after four weeks. However, we observed a decrease of prefrontal theta cordance after the first week of clomipramine therapy. Manic symptoms emerged after two weeks of clomipramine treatment. A decrease of prefrontal theta cordance preceded the clomipramine induced switch to hypomania during the next episode of depression also. LORETA before and during clomipramine therapies detected a significant increase of theta in the right postcentralis gyrus in the parietal lobe, and a borderline increase of alfa2 in the right middle frontal gyrus. DISCUSSION: In a patient with bipolar spectrum disorder we found that a treefold change in theta prefrontal cordance preceded mood changes in a similar way as in patients with unipolar depression. We speculate that the changes detected by LORETA can attributed to the anticholinergic activity of clomipramine and the specific effects of a mood switch. Our data suggest that the new applications of QEEG can be sensitive to mood changes and have potential in bipolar disorder research.


Subject(s)
Bipolar Disorder/physiopathology , Electroencephalography , Antidepressive Agents, Tricyclic/therapeutic use , Bipolar Disorder/drug therapy , Bipolar Disorder/pathology , Brain/pathology , Clomipramine/therapeutic use , Depression/drug therapy , Depression/pathology , Depression/physiopathology , Humans , Magnetoencephalography , Male , Middle Aged , Parietal Lobe/physiology , Receptors, Drug/drug effects , Theta Rhythm
9.
Eur Psychiatry ; 23(5): 350-5, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18450430

ABSTRACT

INTRODUCTION: Previous studies of patients with unipolar depression have shown that early decrease of prefrontal EEG cordance in theta band can predict clinical response to various antidepressants. We have now examined whether decrease of prefrontal quantitative EEG (QEEG) cordance value after 1 week of venlafaxine treatment predicts clinical response to venlafaxine in resistant patients. METHOD: We analyzed 25 inpatients who finished 4-week venlafaxine treatment. EEG data were monitored at baseline and after 1 week of treatment. QEEG cordance was computed at three frontal electrodes in theta frequency band. Depressive symptoms and clinical status were assessed using Montgomery-Asberg Depression Rating Scale (MADRS), Beck Depression Inventory-Short Form (BDI-S) and Clinical Global Impression (CGI). RESULTS: Eleven of 12 responders (reduction of MADRS >or=50%) and only 5 of 13 non-responders had decreased prefrontal QEEG cordance value after the first week of treatment (p=0.01). The decrease of prefrontal cordance after week 1 in responders was significant (p=0.03) and there was no significant change in non-responders. Positive and negative predictive values of cordance reduction for response were 0.7 and 0.9, respectively. CONCLUSION: The reduction of prefrontal theta QEEG cordance value after first week of treatment might be helpful in the prediction of response to venlafaxine.


Subject(s)
Cyclohexanols/therapeutic use , Depressive Disorder, Major/drug therapy , Depressive Disorder, Major/physiopathology , Electroencephalography , Prefrontal Cortex/physiopathology , Selective Serotonin Reuptake Inhibitors/therapeutic use , Theta Rhythm , Adolescent , Adult , Depressive Disorder, Major/diagnosis , Female , Humans , Male , Middle Aged , Personality Disorders/diagnosis , Personality Disorders/epidemiology , Predictive Value of Tests , Treatment Outcome , Venlafaxine Hydrochloride
10.
Neuro Endocrinol Lett ; 28(4): 524-6, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17693989

ABSTRACT

We present a case report of a 37-year old woman diagnosed with depressive disorder, first episode, who was admitted into a psychiatric hospital after a failed suicidal attempt. She responded to antidepressant therapy, as evidenced by a >50% reduction in MADRS total score. She was discharged after 4 weeks of treatment, denying any suicidal ideations. The following day the patient committed suicide; she burned herself to death. It is very likely that the patient dissimulated her symptoms and ideations. Subsequently, her quantitative EEG records were retrospectively analyzed. An increase of prefrontal theta cordance value after the first week of mirtazapine therapy was found. Recently three small studies have revealed that decrease of prefrontal theta cordance after 1 week of antidepressant administration can predict clinical response in patients with unipolar depression. In our previous study the absence of a decreased theta prefrontal cordance was associated with lack of treatment response with NPV 1.0 (Bares et al., 2007). Thus, we hypothesize that prefrontal theta cordance could become an objective marker of change of depressive symptoms, independent of patients' compliance and symptom dissimulation, more precise than objective and self-rated depression rating scales.


Subject(s)
Depression/diagnosis , Depression/psychology , Prefrontal Cortex/physiopathology , Theta Rhythm , Adult , Antidepressive Agents, Tricyclic/therapeutic use , Depression/drug therapy , Fatal Outcome , Female , Humans , Mianserin/analogs & derivatives , Mianserin/therapeutic use , Mirtazapine , Prefrontal Cortex/drug effects , Retrospective Studies , Suicide
12.
Clin Neurophysiol ; 117(9): 2050-8, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16887384

ABSTRACT

OBJECTIVE: To test the discriminatory topographic potential of a new method of the automatic EEG analysis in neonates. A quantitative description of the neonatal EEG can contribute to the objective assessment of the functional state of the brain, and may improve the precision of diagnosing cerebral dysfunctions manifested by 'disorganization', 'dysrhythmia' or 'dysmaturity'. METHODS: 21 healthy, full-term newborns were examined polygraphically during sleep (EEG-8 referential derivations, respiration, ECG, EOG, EMG). From each EEG record, two 5-min samples (one from the middle of quiet sleep, the other from the middle of active sleep) were subject to subsequent automatic analysis and were described by 13 variables: spectral features and features describing shape and variability of the signal. The data from individual infants were averaged and the number of variables was reduced by factor analysis. RESULTS: All factors identified by factor analysis were statistically significantly influenced by the location of derivation. A large number of statistically significant differences were also established when comparing the effects of individual derivations on each of the 13 measured variables. Both spectral features and features describing shape and variability of the signal are largely accountable for the topographic differentiation of the neonatal EEG. CONCLUSIONS: The presented method of the automatic EEG analysis is capable to assess the topographic characteristics of the neonatal EEG, and it is adequately sensitive and describes the neonatal electroencephalogram with sufficient precision. SIGNIFICANCE: The discriminatory capability of the used method represents a promise for their application in the clinical practice.


Subject(s)
Brain Mapping , Brain/physiology , Electroencephalography , Factor Analysis, Statistical , Female , Humans , Infant, Newborn , Male , Sleep Stages/physiology
13.
Sleep Med ; 4(6): 543-52, 2003 Nov.
Article in English | MEDLINE | ID: mdl-14607349

ABSTRACT

BACKGROUND AND PURPOSE: The aim of the present study was to verify whether the proposed method of computer-supported EEG analysis is able to differentiate the EEG activity in quiet sleep (QS) from that in active sleep (AS) in newborns. A quantitative description of the neonatal EEG may contribute to a more exact evaluation of the functional state of the brain, as well as to a refinement of diagnostics of brain dysfunction manifesting itself frequently as 'dysrhythmia' or 'dysmaturity'. PATIENTS AND METHODS: Twenty-one healthy newborns (10 full-term and 11 pre-term) were examined polygraphically (EEG-eight channels, respiration, ECG, EOG and EMG) in the course of sleep. From each EEG record, two 5-min samples (one from QS and one from AS) were subject to an off-line computerized analysis. The obtained data were averaged with respect to the sleep state and to the conceptional age. The number of variables was reduced by means of factor analysis. RESULTS: All factors identified by factor analysis were highly significantly influenced by sleep states in both developmental periods. Likewise, a comparison of the measured variables between QS and AS revealed many statistically significant differences. The variables describing (a) the number and length of quasi-stationary segments, (b) voltage and (c) power in delta and theta bands contributed to the greatest degree to the differentiation of EEGs between both sleep states. CONCLUSION: The presented method of the computerized EEG analysis which has good discriminative potential is adequately sensitive and describes the neonatal EEG with convenient accuracy.


Subject(s)
Brain/physiopathology , Electroencephalography , Sleep/physiology , Diagnosis, Computer-Assisted , Electrocardiography , Electromyography , Electrooculography , Humans , Infant, Newborn , Models, Biological
14.
Neuropsychobiology ; 48(1): 19-26, 2003.
Article in English | MEDLINE | ID: mdl-12886036

ABSTRACT

The aim of the study was to elaborate a method to estimate the degree of cognitive impairment in Alzheimer's disease from the EEG quantitative indicators. We examined 38 unmedicated patients with a diagnosis of Alzheimer's disease, with various stages (mild, moderate, and severe) of dementia. The EEG recordings were evaluated both visually and by means of computer analysis. The EEG spectra and coherences in 6 frequency bands were calculated in 16 EEG derivations. Among various EEG indicators, a decrease in the alpha coherence and an increase in the delta coherence was found to be most significantly correlated to the degree of dementia. Combining 6 variables from the spectrum and coherence analysis by means of the multiple regression model, a high correlation (r = 0.87) between a set of EEG variables and the Mini-Mental State Examination score could be obtained. The results suggest that the EEG can supplement the clinical examination by providing an independent assessment of the degree of dementia. The results also suggest that the EEG coherences are of particular interest in dementia, being an indicator of the signal transfer between various parts of the brain cortex.


Subject(s)
Alzheimer Disease/diagnosis , Dementia/diagnosis , Electroencephalography/methods , Outcome Assessment, Health Care , Aged , Aged, 80 and over , Alzheimer Disease/classification , Alzheimer Disease/physiopathology , Cognition Disorders/diagnosis , Cognition Disorders/physiopathology , Dementia/physiopathology , Female , Humans , Male , Mental Status Schedule , Middle Aged , Monitoring, Physiologic , Neuropsychological Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...